1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Virology Market – By Type

1.3.2        SAM Virology Market – By Application

1.3.3        SAM Virology Market – By End User

1.3.4        SAM Virology Market– By Country

2.           SAM Virology Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Virology Market– Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Experts Opinion

5.           SAM Virology Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Viral Infectious Diseases

5.1.2        Surging Product Launches

5.2         Market Restraints

5.2.1        Availability of Alternative Products and High Cost of Production of Products

5.3         Market Opportunities

5.3.1        Immense Growth Potential in Emerging Economies

5.4         Future Trends

5.4.1        Continuous Demand for Cost-Effective Products

5.5         Impact Analysis

6.           Virology Market– SAM Analysis

6.1         SAM Virology Market Revenue Forecast and Analysis

7.           SAM Virology Market Analysis – By Type

7.1         Overview

7.2         SAM Virology Market Revenue Share, by Type (2021 and 2028)

7.3         Diagnostic Test

7.3.1        Overview

7.3.2        Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1          Overview

7.3.2.1.2          DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1          Overview

7.3.2.2.2          RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Others

7.3.2.3.1          Overview

7.3.2.3.2          Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Viral Infection Controlling Techniques

7.4.1        Overview

7.4.2        Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1          Active Prophylaxis

7.4.2.1.1          Overview

7.4.2.1.2          Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2          Passive Prophylaxis

7.4.2.2.1          Overview

7.4.2.2.2          Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Antiviral Therapeutics

7.5.1        Overview

7.5.2        Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1          Virucidal Agents

7.5.2.1.1          Overview

7.5.2.1.2          Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2          Antiviral Agents

7.5.2.2.1          Overview

7.5.2.2.2          Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3          Immunomodulators

7.5.2.3.1          Overview

7.5.2.3.2          Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Interferons

7.6.1        Overview

7.6.2        Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.           SAM Virology Market Analysis – By Application

8.1         Overview

8.2         SAM Virology Market, by Application 2021 & 2028 (%)

8.3         Skin and Soft Tissue Infections

8.3.1        Overview

8.3.2        Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Respiratory Tract Infections

8.4.1        Overview

8.4.2        Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5         GI Tract Infections

8.5.1        Overview

8.5.2        GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Sexually Transmitted Diseases

8.6.1        Overview

8.6.2        Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Urinary Tract Infections

8.7.1        Overview

8.7.2        Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.           SAM Virology Market Analysis – By End User

9.1         Overview

9.2         SAM Virology Market Revenue Share, by End User (2021 and 2028)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Diagnostic Laboratories

9.4.1        Overview

9.4.2        Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Pharmaceutical and Biotechnological Companies

9.5.1        Overview

9.5.2        Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Research and Academic Institutes

9.6.1        Overview

9.6.2        Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.        SAM Virology Market – Country Analysis

10.1.1     Overview

10.1.2     South America: Virology Market, by Country, 2021 & 2028 (%)

10.1.2.1       Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       Brazil: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1    Brazil: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.1.2.2    Brazil: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.1.2.3    Brazil: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.1.3       Brazil: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4       Brazil: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.2       Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       Argentina: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1    Argentina: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.2.2.2    Argentina: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.2.2.3    Argentina: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.2.3       Argentina: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4       Argentina: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.3       Rest of South America: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       Rest of South America: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       Rest of South America: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1    Rest of South America: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.3.2.2    Rest of South America: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.3.2.3    Rest of South America: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.3.3       Rest of South America: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4       Rest of South America: Virology Market, by End User, 2019–2028 (USD Million)

11.        Impact of COVID-19 Pandemic on SAM Virology Market

11.1      Overview

12.        SAM Virology Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Abbott

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Johnson and Johnson Services, Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      F. HOFFMANN-LA ROCHE LTD.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      THERMO FISHER SCIENTIFIC INC.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      QIAGEN

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Illumina, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Siemens AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      GlaxoSmithKline Plc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      AbbVie Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Gilead Sciences, Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

Table 1.             SAM Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5.             Brazil Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6.             Brazil: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             Brazil: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 8.             Argentina: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             Argentina Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10.          Argentina Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11.          Argentina Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12.          Argentina: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          Argentina: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of South America: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of South America Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of South America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million

Table 17.          Rest of South America Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of South America: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of South America: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 20.          Organic Developments Done by Companies

Table 21.          Inorganic Developments Done by Companies

Table 22.          Glossary of Terms, SAM Virology Market

Figure 1.           SAM Virology Market Segmentation

Figure 2.           SAM Virology Segmentation, By Country

Figure 3.           SAM Virology Market Overview

Figure 4.           Antiviral Therapeutics Held the Largest Share of the Type Segment in SAM Virology Market

Figure 5.           Respiratory Tract Infections Held the Largest Share of the Application Segment in SAM Virology Market

Figure 6.           Brazil to Show Significant Growth During Forecast Period

Figure 7.           SAM PEST Analysis

Figure 8.           SAM Virology Market: Impact Analysis of Drivers and Restraints

Figure 9.           SAM Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10.        SAM Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11.        SAM Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        SAM DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        SAM RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        SAM Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        SAM Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        SAM Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        SAM Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        SAM Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        SAM Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        SAM Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        SAM Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        SAM Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        SAM Virology Market, by Application 2021 & 2028 (%)

Figure 24.        SAM Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        SAM Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        SAM GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        SAM Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        SAM Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        SAM Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        SAM Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31.        SAM Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        SAM Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        SAM Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        SAM Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        South America: Virology Market, by Key Country – Revenue (2021) (USD Million)

Figure 36.        South America: Virology Market, by Country, 2021 & 2028 (%)

Figure 37.        Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Rest of South America: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Impact of COVID-19 Pandemic on Virology Market in SAM Countries